Achieving value and sustainability in prescribing medication: consultation

Closes 8 Sep 2024

This service needs cookies enabled.

Oxycodone and Naloxone combination product

Recommendations

  • do not initiate in primary or secondary care
  • deprescribe in individuals currently prescribed this item
13a. Do you agree or disagree with the recommendation that prescribers should not initiate oxycodone and naloxone for any new individuals?
13b. Do you agree or disagree with the recommendation to deprescribe oxycodone and naloxone combination product in all individuals?
13c. Please provide any further comments on the recommendations for oxycodone and naloxone.